Lessons from 5 Years of Routine Whole-Genome Sequencing for Epidemiologic Surveillance of Shiga Toxin–Producing Escherichia coli, France, 2018–2022

IF 7.2 2区 医学 Q1 IMMUNOLOGY
Gabrielle Jones, Carolina Silva Nodari, Laëtitia Fabre, Henriette de Valk, Harold Noel, Aurélie Cointe, Stéphane Bonacorsi, François-Xavier Weill, Yann Le Strat
{"title":"Lessons from 5 Years of Routine Whole-Genome Sequencing for Epidemiologic Surveillance of Shiga Toxin–Producing Escherichia coli, France, 2018–2022","authors":"Gabrielle Jones, Carolina Silva Nodari, Laëtitia Fabre, Henriette de Valk, Harold Noel, Aurélie Cointe, Stéphane Bonacorsi, François-Xavier Weill, Yann Le Strat","doi":"10.3201/eid3113.241950","DOIUrl":null,"url":null,"abstract":"<p>Whole-genome sequencing (WGS) is routine for surveillance of Shiga toxin–producing <em>Escherichia coli</em> human isolates in France. Protocols use EnteroBase hierarchical clustering at <span>&lt;</span>5 allelic differences (HC5) as screening for cluster detection. We assessed current implementation after 5 years for 1,002 sequenced isolates. From genomic distances of serotypes O26:H11, O157:H7, O80:H2, and O103:H2, we determined statistical thresholds for cluster determination and compared those with HC5 clusters. Thresholds varied by serotype, 5–16 allelic distances and 15–20 single-nucleotide polymorphisms, showing limits of a single-threshold approach. We confirmed validity of HC5 screening for 3 serotypes because statistical thresholds had limited effect on isolate clustering (high sensitivity and specificity). For O80:H2, results suggest that HC5 is less reliable, and other approaches should be explored. Public health officials should regularly assess WGS used for Shiga toxin–producing <em>E. coli</em> surveillance to account for serotype and genomic evolution and to interpret WGS-linked isolates in light of epidemiologic data.</p>","PeriodicalId":11595,"journal":{"name":"Emerging Infectious Diseases","volume":"67 1","pages":""},"PeriodicalIF":7.2000,"publicationDate":"2025-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Emerging Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3201/eid3113.241950","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Whole-genome sequencing (WGS) is routine for surveillance of Shiga toxin–producing Escherichia coli human isolates in France. Protocols use EnteroBase hierarchical clustering at <5 allelic differences (HC5) as screening for cluster detection. We assessed current implementation after 5 years for 1,002 sequenced isolates. From genomic distances of serotypes O26:H11, O157:H7, O80:H2, and O103:H2, we determined statistical thresholds for cluster determination and compared those with HC5 clusters. Thresholds varied by serotype, 5–16 allelic distances and 15–20 single-nucleotide polymorphisms, showing limits of a single-threshold approach. We confirmed validity of HC5 screening for 3 serotypes because statistical thresholds had limited effect on isolate clustering (high sensitivity and specificity). For O80:H2, results suggest that HC5 is less reliable, and other approaches should be explored. Public health officials should regularly assess WGS used for Shiga toxin–producing E. coli surveillance to account for serotype and genomic evolution and to interpret WGS-linked isolates in light of epidemiologic data.

2018-2022年产志贺毒素大肠杆菌流行病学监测5年常规全基因组测序经验
在法国,全基因组测序(WGS)是监测产志贺毒素大肠杆菌人类分离株的常规方法。协议使用EnteroBase在5个等位基因差异(HC5)上的分层聚类作为聚类检测的筛选。我们对1002株测序菌株进行了5年后的评估。根据血清型O26:H11、O157:H7、O80:H2和O103:H2的基因组距离,我们确定了聚类判定的统计阈值,并与HC5聚类进行了比较。阈值因血清型、5-16个等位基因距离和15-20个单核苷酸多态性而异,显示单一阈值方法的局限性。我们确认了3种血清型HC5筛查的有效性,因为统计阈值对分离聚类的影响有限(高灵敏度和特异性)。对于O80:H2,结果表明HC5不太可靠,应该探索其他方法。公共卫生官员应定期评估用于产志贺毒素大肠杆菌监测的WGS,以解释血清型和基因组进化,并根据流行病学数据解释与WGS相关的分离株。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Emerging Infectious Diseases
Emerging Infectious Diseases 医学-传染病学
CiteScore
17.30
自引率
1.70%
发文量
505
审稿时长
1 months
期刊介绍: Emerging Infectious Diseases is a monthly open access journal published by the Centers for Disease Control and Prevention. The primary goal of this peer-reviewed journal is to advance the global recognition of both new and reemerging infectious diseases, while also enhancing our understanding of the underlying factors that contribute to disease emergence, prevention, and elimination. Targeted towards professionals in the field of infectious diseases and related sciences, the journal encourages diverse contributions from experts in academic research, industry, clinical practice, public health, as well as specialists in economics, social sciences, and other relevant disciplines. By fostering a collaborative approach, Emerging Infectious Diseases aims to facilitate interdisciplinary dialogue and address the multifaceted challenges posed by infectious diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信